Valuation: Pathkey.AI Ltd

Market Cap 41.28M 28.59M 25.12M 23.45M 21.52M 40.29M 2.74B 278M 109M 1.36B 107M 105M 4.68B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 41.26M 28.57M 25.11M 23.44M 21.51M 40.26M 2.74B 278M 109M 1.35B 107M 105M 4.68B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day+11.11%
1 week-21.05%
Current month-55.88%
1 month-55.88%
3 months-43.40%
6 months+50.00%
Current year+87.50%
1 week 0.03
Extreme 0.027
0.04
1 month 0.03
Extreme 0.027
0.07
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3.4
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%-21.05%+42.86%-38.78% 12.71M
+3.33%+12.66%-27.62%+3.21% 32.68B
-1.37%-0.20%-49.40%+135.21% 11.89B
+1.51%+4.12%-23.25%+67.57% 5.54B
-2.15%+3.34% - - 2.21B
-3.83%+1.32%+39.79%-34.24% 1.96B
-0.46%-5.90% - - 1.68B
+1.07%-3.44%-37.10% - 1.01B
-2.72%-0.92%+30.00%+97.70% 871M
+0.89%+3.99%-41.95%-54.07% 769M
Average +0.74%-2.41%-8.33%+25.23% 5.86B
Weighted average by Cap. +1.50%+5.28%-28.94%+38.40%

Financials

2024 2025
Net sales 398K 275K 242K 226K 207K 388K 26.38M 2.68M 1.05M 13.05M 1.03M 1.01M 45.13M 322K 223K 196K 183K 168K 314K 21.36M 2.17M 848K 10.57M 837K 819K 36.54M
Net income -3.13M -2.17M -1.91M -1.78M -1.63M -3.06M -208M -21.09M -8.25M -103M -8.14M -7.96M -355M -1.45M -1M -881K -822K -755K -1.41M -96.05M -9.75M -3.81M -47.53M -3.76M -3.68M -164M
Net Debt -375K -259K -228K -213K -195K -366K -24.85M -2.52M -987K -12.3M -974K -953K -42.52M -25.17K -17.43K -15.32K -14.3K -13.12K -24.56K -1.67M -170K -66.3K -826K -65.44K -64.02K -2.86M
Logo Pathkey.AI Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
30/07/26 $0.0300 +11.11% 981,859
29/07/26 $0.0270 -10.00% 1,188,390
28/07/26 $0.0300 -3.23% 2,249,710
27/07/26 $0.0310 0.00% 3,094,386
24/07/26 $0.0310 -18.42% 4,049,389